Naar; Anders M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Naar; Anders M..The latest application filed is for "therapeutic targeting of a microrna to treat duchenne muscular dystrophy".

Company Profile

6.12.22

Naar; Anders M. - Arlington MA
NAAR; Anders M. - Berkeley CA
Naar; Anders M - Arlington MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic Targeting of a microRNA to Treat Duchenne Muscular Dystrophy App 20220213477 - Naar; Anders M. ; et al.	2022-07-07
Oligonucleotides And Methods For The Treatment Of Age-related Maculardegeneration App 20220195428 - NAAR; Anders M. ; et al.	2022-06-23
Agents And Methods For Treating Pancreatic Ductal Adenocarcinomas App 20220152081 - Mostoslavsky; Raul ; et al.	2022-05-19
Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy Grant 11,236,336 - Naar , et al. February 1, 2	2022-02-01
Agents And Methods For Treating Pancreatic Ductal Adenocarcinomas App 20210030781 - Mostoslavsky; Raul ; et al.	2021-02-04
Therapeutic Targeting of a microRNA to Treat Duchenne Muscular Dystrophy App 20200362342 - Naar; Anders M. ; et al.	2020-11-19
Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy Grant 10,626,395 - Naar , et al.	2020-04-21
Agents and methods for treating pancreatic ductal adenocarcinomas Grant 10,588,920 - Mostoslavsky , et al.	2020-03-17
Targeting Human Satellite Ii (hsatii) App 20200017856 - Ting; David T. ; et al.	2020-01-16
Therapeutic Targeting of a microRNA to Treat Duchenne Muscular Dystrophy App 20190270993 - Naar; Anders M. ; et al.	2019-09-05
Targeting human satellite II (HSATII) Grant 10,301,624 - Ting , et al.	2019-05-28
Regulation Of Mir-33 Micrornas In The Treatment Of Cholesterol-related Disorders App 20180119148 - NAAR; Anders M.	2018-05-03
Agents And Methods For Treating Pancreatic Ductal Adenocarcinomas App 20180085389 - Mostoslavsky; Raul ; et al.	2018-03-29
Methods targeting miR-128 for regulating cholesterol/lipid metabolism Grant 9,789,132 - Naar , et al. October 17, 2	2017-10-17
Regulation Of Mir-33 Micrornas In The Treatment Of Cholesterol-related Disorders App 20170233730 - NAAR; Anders M.	2017-08-17
Targeting Human Satellite Ii (hsatii) App 20170198288 - Ting; David T. ; et al.	2017-07-13
Methods Targeting Mir-128 For Regulating Cholesterol/lipid Metabolism App 20170042931 - Naar; Anders M. ; et al.	2017-02-16
Methods targeting miR-128 for regulating cholesterol/lipid metabolism Grant 9,476,046 - Naar , et al. October 25, 2	2016-10-25
Agents And Methods For Inhibiting Mir-148a For The Modulation Of Cholesterol Levels App 20160186171 - NAAR; Anders M. ; et al.	2016-06-30
Methods Targeting Mir-128 For Regulating Cholesterol/lipid Metabolism App 20150232848 - Naar; Anders M. ; et al.	2015-08-20
Methods targeting miR-128 for regulating cholesterol/lipid metabolism Grant 9,045,749 - Naar , et al. June 2, 2	2015-06-02
Methods targeting miR-33 microRNAs for regulating lipid metabolism Grant 8,859,519 - Naar October 14, 2	2014-10-14
Methods Targeting Mir-128 For Regulating Cholesterol/lipid Metabolism App 20140051746 - Naar; Anders M. ; et al.	2014-02-20
High throughput screens for small-molecule inhibitors of the nuclear receptor-like pathway regulating multidrug resistance in fungi Grant 8,557,746 - Naar , et al. October 15, 2	2013-10-15
Methods Targeting Mir-33 Micrornas For Regulating Lipid Metabolism App 20130245093 - Naar; Anders M.	2013-09-19
Regulation of MIR-33 MicroRNAs in the Treatment of Cholesterol-Related Disorders App 20120053229 - Naar; Anders M	2012-03-01
High Throughput Screens For Small-molecule Inhibitors Of The Nuclear Receptor-like Pathway Regulating Multidrug Resistance In Fungi App 20100273676 - Naar; Anders M. ; et al.	2010-10-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.